Mandag, Lita B.
HRN: 12-11-79 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/30/2024
ERYTHROMYCIN 0.5%, 3.5G EYE OINTMENT (TUBE)
01/30/2024
02/06/2024
TOPICAL
Sufficient Amount
BID
Blepharitis
Waiting Final Action
Indication: Empiric Type of Infection: Eye, Ear, Nose, Throat, & Mouth Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes